Bilirubin, Direct, Serum
Unconjugated bilirubin (Indirect bilirubin) is a product of hemoglobin metabolism. It is created during the process of red blood cell destruction and is transported to the liver as a complex with serum albumin. In the liver, bilirubin is conjugated with glucuronic acid to make ‘Conjugated Bilirubin (direct bilirubin) which is water soluble. Conjugated bilirubin is then transported through the bile duct for elimination via the digestive tract. Both conjugated (direct) and unconjugated (indirect) forms of bilirubin circulate loosely bound to albumin.
The assessment of direct bilirubin is helpful in the assessment of liver function. The increase in the total bilirubin associated with obstructive jaundice is primarily due to the direct fraction. Both direct and indirect bilirubin are increased in the serum in patients with hepatitis. In newborn infants with neonatal jaundice, the increase in the total bilirubin is primarily due to the indirect bilirubin fraction. Neonatal jaundice exacerbated by maternal antibodies from Rh, ABO, or other blood group incompatibilities, by hepatic immaturity, or by hereditary defects in bilirubin conjugation. Because the newborn blood-brain barrier is immature, the unconjugated bilirubin may cross into the central nervous system causing damage (kernicterus).
- Diagnosis of liver diseases/disorders
- As an aid in diagnosis of biliary tract obstructive disease
- As an aid in diagnosis of liver abnormalities such as Dubin-Johnson syndrome, Rotor syndrome, Gilbert’s syndrome, and Crigler-Najjar syndrome
- As an aid in diagnosis of infectious and other type of hepatitis
Increased in:
- Acute or chronic hepatitis
- Cirrhosis
- Biliary tract obstruction
- Toxic hepatitis
- Congenital liver enzyme abnormalities (Dubin-Johnson, Rotor, Gilbert, Crigler-Najjar syndromes)
- Hemolytic disorders
- Ingestion of hepatotoxic drugs or other hepatotoxins
| Population | Reference Range |
| Adults | ≤ 0.4 mg/dL (SI: ≤ 7 μmol/L) |
| Newborns | Reference Range |
| 24 hours | 8.0 mg/dL (≤ 137 μmol/L (≤) |
| 48 hours | ≤ 14.0 mg/dL (≤ 239 μmol/L) |
| 84 hours | ≤ 17.0 mg/dL (≤ 290 μmol/L) |
Serum (SST tubes).
Stability When well protected from light, bilirubin in serum is stable for up to 3 days at 2 - 8°C and for approximately three months when stored at ≤-20°C
- Am Fam Physician. 1992 Mar;45(3):1139-48. [PMID: 1543099]
- Am Fam Physician. 2004;69:299. [PMID: 14765767]
- Clin Cornerstone. 2001;3(6):1-12. [PMID: 11501190]
- CMAJ. 2005;172:367. [PMID: 15684121]
- Tietz, N.W.(ed), Fundamentals of Clinical Chemistry, 3rd Edition, W.B. Saunders, 1987.
- Young, D.S., Effects of Drugs on Clinical Laboratory Tests, 5th Edition, AACC Press, 2000.